P84DT22H2M13S
Past Conference Information
About Conference
On Tremendous success of our Dementia Conference-2017, 2nd Innovations and State of the Art In Dementia Research” will takes place on July 16 - 18, 2018, Valencia, Spain with the theme "Delivering on dementia: new models of care". Dementia is a national challenge and has ramifications for the health and social care system, as well as wider society. Dementia mostly affects aged people; Dementia is a disorder, more often it is of chronic or progressive nature, developed by an assortment of brain illnesses that influence thinking, memory, behaviour and ability to perform daily activities. Dementia is overwhelming for the general population who have it, as well as for their caregivers and families.
Building on the progress made in dementia care, a key theme of our conference was to showcase and learn from what works. The conference aims to provide guidance in the advancement of clinical studies for the treatment of dementia fusing new research information and experiences from the most recent clinical trials and development programs. The scientific sessions addresses not just the Alzheimer's disease as the most widely recognized type of dementia, however ought to be relevant to different types of dementia as vascular dementia, dementia connected with Parkinson's disease and Lewy Body Disorder, Huntington's disease or fronto-temporal dementia too.
Mark your calendars now and stay tuned for more information.
Latest News
Things to Know About Alzheimer’s
Alzheimer’s disease (AD) is a neurodegenerative disorder that makes a person lose their cognitive abilities, altering daily functioning and leading to various levels of physical and emotional stress
Catastrophic’ lack of sleep in modern society is killing us, warns leading sleep scientist
A “catastrophic sleep-loss epidemic” is causing a host of potentially fatal diseases, a leading expert has said
Prince Henrik of Denmark diagnosed with dementia after erratic behaviour causes concern
French-born husband of Queen Margrethe, 83, shocked nation last month with surprise declaration he would not be buried alongside his wife in protest at not being recognised her equal
Dementia: BACE inhibitor improves brain function
The protein amyloid beta is believed to be the major cause of Alzheimer's disease. Substances that reduce the production of amyloid beta, such as BACE inhibitors, are therefore promising candidates for new drug treatments
Less REM sleep tied to greater risk of dementia
People who get less rapid eye movement (REM) sleep may have a greater risk of developing dementia, according to a new study. REM sleep is the sleep stage when dreaming occurs
Organizing Committee
Jacques L. De Reuck
Director of the Ghent Stroke Centre, Belgium
Prof. George Perry
University of Texas at San Antonio, USA
Daniel Farkas
USC/TBW, USA
Harish Pant
National Institutes of Health, USA
Scientific Sessions
Featured Speakers
The Implications of Poor Oral Health in the Elderly
Peter Foltyn
St Vincent's Hospital, Australia
Psychiatry and Psychotherapy
Early-onset Alzheimer's in a 40-year-old woman: Postmortem pathology
Ma. Francisca Tristán-Agundis
Fray Bernardino Álvarez Psychiatric Hospital, México
Dementia Research
Effects of amyloid-? deposition on mitochondrial complex I activity in brain: a PET study in aged monkeys
HIDEO TSUKADA
Central Research Laboratory, Hamamatsu Photonics K.K, Japan
Dementia Research
Side Effect of Cancer Therapy: Chemobrain-mechanisms and interventions
Daret St. Clair
University of Kentucky, USA
Neurological Disorders
Different patterns of mitochondrial DNA mutations in Alzheimer’s and Parkinson’s disease
Tiziana Casoli
Center for Neurobiology of Aging, INRCA IRCCS Ancona, Italy
Risk factors for Dementia
Tau-specific D-enantiomeric peptides for therapeutic applications in Alzheimer’s disease
Susanne Aileen Funke
Hochschule für Angewandte Wissenschaften Coburg, Germany
Dementia Research
VIRTUAL GENE PANEL FOR WHOLE EXOME SEQUENCING STUDIES ON NEURODEGENERATIVE DISEASES
Eva Bagyinszky
Gachon University, South Korea
Diagnosing Dementia
Fixed-dose combination of donepezil hydrochloride and memantine hydrochloride for treatment of moderate to severe Alzheimer's disease
Stevin Zung
Aché Laboratories, Brazil
Pharmacological Treatment of Dementia
ADFlag, a diagnostic blood test for pre-dementia stages of Alzheimer’s disease
Beatice Blanc
ICDD, France
Diagnosing Dementia
Multimodality imaging for clinical research: The role of bio-photonics
Daniel Farkas
USC/TBW, USA
Alzheimer and Neuro Imaging
Neuroprotective role a small peptide derived from neuronal cell cycle like kinase (Cdk5) activator (p35)
Harish Pant
National Institutes of Health, USA
Neurological Disorders
Factors Associated with Anxiety Disorder among ART clients attending ART Clinic at Hawassa Universty Referral Hospital, Hawassa, SNNPR, Ethiopia
Ara Bazyan
Institute of Higher Nervous Activity and Neurophysiology Russian Academy of Science, Russia
Neuropsychology & Neurophysiology
Tetraspanin 6: a key regulator of the lysosomal degradation and exosome release of amyloid precursor protein fragments
Francesc X. Guix
VIB Center for Brain and Disease research - VIB, Spain
Neurodegenerative Diseases
Cmax-based synergistic therapeutic effect on cognitive disability in mild Alzheimer’s disease after 36 weeks treatment with baclofen and acamprosate
Jacques Touchon
faculté de Médecine de Montpellier, France
Alzheimer’s disease
A quantitative assay to measure human cerebrospinal fluid induced membrane permeabilization
Suman De
University of Cambridge, United Kingdom
Dementia Research
The Role of Posttranslational Modifications of Amyloid-? for Neurotoxicity and Resulting Therapeutic Opportunities
Hans-Ulrich Demuth
Fraunhofer IZI-MWT, Germany
Dementia Care Practice
Pathogenic tau protein phosphorylation in ALS, CTE and ALS/CTE: a unifying mechanism
Michael Strong
Western University, Canada
Dementia Research
Prescribing Virtual Reality (VRx): A novel therapy for people living with Dementia/ Cognitive Impairment - Preliminary results from a multi-site study
Lora Appel
OpenLab UHN, Canada
Dementia Care Practice
Patterns of Prevalence and Incidence of Dementia in U.S. Racial/Ethnic Populations
Gwen Yeo
Stanford University, United States
Dementia Research
A potential tri-therapy for Alzheimer’s disease
Rodolphe HAJJ
PHARNEXT, France
Alzheimer and Neuro Imaging
Neurodegeneration study from a population of heroin dependent patients under methadone maintenance therapy
Yu-Li Liu
National Health Research Institutes, Taiwan
Diagnosing Dementia
Dementia among Indigenous populations in Ontario
Laura Warren
University of Toronto, Canada
Dementia Research
A Multifunctional Biocompatible Drug Candidate Effectively Delays the Progression of Alzheimer’s Disease in 5XFAD Mice
Bilha Fischer
Bar-Ilan University , Israel
Pharmacological Treatment of Dementia
Rehabilitation of patients with hip fracture and dementia- clinical implication
Michal Elboim-Gabyzon
University of Haifa, Haifa, Israel
Physical Therapy
Past Conference Gallery
Target Audience
Academic Professors
Neurologists
Neuroscientists
Psychiatrist
Nutritional Scientists
Neurosurgeons
Healthcare clinicians
Educators
Researchers
Why to attend ?
- To Meet renowned speakers, world's leading CEO's, Directors, decision and policy makers.
- To know about the ongoing research projects for Alzheimer's disease & Dementia
- To keep abreast of all advances in Dementia
- Chance to collaborate research organizations with industries
- To share the research ideas and implement them in Dementia diagnosis & Treatment
- Best opportunity to reach the largest assemblage of participants from Dementia Socities
- New contacts to enhance the business opportunities
